IDH1 and astrocytoma (excluding glioblastoma): Additional information on combined CNV load in astrocytoma can be readily integrated into the analysis and further aid the grading and prognostication of IDH-mutant astrocytomas.20 As confidence in these approaches grows, it is likely that traditional morphological methods, such as immunohistochemistry, will become redundant, at least for a subset of cases.